NCT00749372View on ClinicalTrials.gov

MRI Screening for Patients With Myelodysplastic Syndrome (MDS), Who Have Received Multiple Red Blood Cell Transfusions

NACompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

March 29, 2013

Study Completion Date

March 29, 2013

Conditions

Myelodysplastic Syndrome (MDS)

Interventions

OTHER

T2* Cardiac and Liver MRI

Patients will undergo an MRI of the heart and liver.

Trial Locations (1)

10065

Weill Medical College of Cornell University, New York

Sponsors

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Weill Medical College of Cornell University

OTHER